Bronchitis
2 papers
- Human trial2
Latest
1 in 12 monthsJournal of Cardiovascular Development and Disease
A Lifestyle Behavior Score Predicting Cardiovascular and Other Causes of Death in a Cohort of Middle-Aged Men Followed up Until Extinction
Cohort study of 1,712 peopleBiomarkers
The Lancet Oncology
Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity
Non-randomised trial in 55 peopleSenolytics
The New England Journal of Medicine
Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis
Non-randomised trial in 28 peoplemTOR inhibitors